Narayana Hrudayalaya Limited lists on the stock exchanges - Buntara Sangam

Breaking

Post Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Tuesday, January 12, 2016

Narayana Hrudayalaya Limited lists on the stock exchanges

The equity shares opened at Rs. 291, touched a high of Rs. 345.65 and closed at Rs. 340.80 on the NSE

Bunt-Bunts-Buntara-sangam-Shakuntala Shetty-Viren-Shetty-Dr-Devi-Shetty- Narayana Hrudayalaya-BSE-NSE
Mrs. Shakuntala Shetty, Mr. Viren Shetty (ED) and Dr. Devi Shetty (Chairman and ED) pose with the bull during the listing ceremony of Narayana Hrudayalaya Ltd. in BSE

Narayana Hrudayalaya Limited (the “Company” or “Issuer”) listed on the stock exchanges after successfully completing an Initial Public Offer of 24,523,297 Equity Shares of Face Value of Rs. 10 Each ("Equity Shares") for Cash at a Price of Rs. 250 Per Equity Share including  Share Premium of Rs. 240 per Equity Share ("Offer") aggregating Rs. 6,130.82 million ("Offer Price") through an Offer for Sale of 6,287,978 Equity Shares by Ashoka Investment Holdings Limited, 1,886,455 Equity Shares by Ambadevi Mauritius Holding Limited, 12,261,648 Equity Shares by JP Morgan Mauritius Holdings IV Limited (The "Investor Selling Shareholders"), 2,043,608 Equity Shares By Dr. Devi Prasad Shetty and 2,043,608 Equity Shares by Shakuntala Shetty (the "Promoter Selling Shareholders") (together the "Selling Shareholders") aggregating to Rs. 6,130.82 million ("Offer For Sale"). The Offer constitutes approximately 12% of the Company’s Post-Offer Paid-Up Share Capital.


Present on the occasion were Dr. Devi Shetty (Chairman and ED), Dr. Ashutosh Raghuvanshi (MD and CEO), Mr. Kesavan Venugopalan (Group CFO), Viren Shetty (ED), Mr. Dharmesh Mehta (Axis Capital Ltd.), Mr. Venkatraghavan S (IDFC), Ashwin Pai (Jefferies India Pvt. Ltd.) and Mr. Balasubramanian V (BSE Ltd.). Mrs. Shakuntala Shetty and Ms. Kiran Mazumdar Shaw (CMD, Biocon Ltd. and Director, Narayana Hrudayalaya Ltd.) also graced the occasion.

The equity shares of the Company opened at Rs. 291 and touched a high of Rs. 344 before closing the day at Rs. 336.70 on the BSE. The equity shares opened at Rs. 291, touched a high of Rs. 345.65 and closed at Rs. 340.80 on the NSE.

The Book Running Lead Managers (“BRLMs”) to the Offer are Axis Capital Limited, IDFC Securities Limited, and Jefferies India Private Limited.

Founded in 2000 by Promoter, Dr. Devi Prasad Shetty, who has over 30 years of medical experience, including as a cardiac surgeon, the Company is one of the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary and primary healthcare facilities. As of the date of the Red Herring Prospectus, it had a network of 23 hospitals (multispeciality and super speciality healthcare facilities which provide tertiary care), 8 heart centres (super speciality units which are set up in a third party hospital) and 24 primary care facilities (including clinics and information centres), across a total of 31 cities, towns and villages in India, with 5,442 operational beds and the potential to reach a capacity of up to 6,602 beds. In FY 2015, the facilities provided care to over 1.97 million patients. Headquartered in Bengaluru, it operates a national network of hospitals in India with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in western and central India. As of September 30, 2015, it had 11,163 employees, which included 344 doctors, 5,587 nurses, 1,996 paramedical staff and 3,236 administrative personnel. Additionally, it had 487 students, which included 469 doctors, 14 paramedics, and 4 administrative trainees. Further, it had 1,750 doctors on a consultancy basis (including visiting consultants) engaged in the system. For further details, please see the section titled "Our Business" on page 121 of the RHP.

Some of the investors include: Government Of Singapore, Monetary Authority Of Singapore, FIL Investments (Mauritius) Limited, Mirae Asset Asia Sector Leader Equity Fund, Reliance Capital Trustee Co. Ltd A/C Reliance Pharma Fund, Reliance Capital Trustee Co Ltd.A/C- Reliance Regular Savings Fund - Balanced Option, Birla Sunlife Trustee Company Private Limited A/C Birla Sun Life Advantage Fund, Birla Sunlife Trustee Company Private Limited A/C Birla Sunlife Midcap Fund, Hdfc Trustee Company Limited A/C Hdfc Growth Fund, Hdfc Trustee Company Ltd - Hdfc Core And Satellite Fund,    Icici Prudential Growth Fund Series – 6, Icici Prudential Growth Fund Series – 7, Icici Prudential Growth Fund Series – 5, Dsp Blackrock Small And Mid Cap Fund, Uti - Master Equity Plan Unit Scheme, Uti - Pharma & Healthcare Fund, India Pharma Fund Unit Scheme Option A, Morgan Stanley Sicav Mauritius Limited, Chennai 2007, C/O Harvard Management Co. Inc, Morgan Stanley Mauritius Company Limited,  The Nomura Trust and Banking Co., Ltd As The Trustee Of Nomura India Stock Mother Fund, Sbi Pharma Fund, Sbi Magnum Midcap Fund, Sbi Equity Opportunities Fund - Series Iv,  Sbi Magnum Childrens Benefit Plan and Sbi Resurgent India Opportunities Scheme.

Disclaimer:

NARAYANA HRUDAYALAYA LIMITED is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its Equity Shares and has filed the RHP with the Registrar of Companies, Bengaluru, Karnataka. The RHP shall be available on the websites of SEBI, BSE, NSE at www.sebi.gov.inwww.bseindia.com and www.nseindia.com respectively, the Company at www.narayanahealth.org, and BRLMs at www.axiscapital.co.inwww.idfccapital.com and www.jefferies.com. Any Potential Investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, see the section titled “Risk Factors” on page 17 of the RHP.

The Equity Shares have not been and will not be registered under the US Securities Act of 1933 ("Securities Act") and may not be offered or sold within the United States (as defined in Regulation S under the Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Equity Shares are only being offered and sold outside the United States in offshore transactions in compliance with Regulation S under the Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. The Equity Shares have not been and will not be registered, listed or otherwise qualified in any other jurisdiction outside India and may not be offered or sold, and Bids may not be made by persons in any such jurisdiction, except in compliance with the applicable laws of such jurisdiction.


This press release is only for information purposes. This is not a Prospectus announcement and does not constitute an invitation or offer to acquire, purchase or subscribed to securities. The statutory ads have been released on December 10, 2015, and investors can refer to the same. All capitalised terms used and not specifically defined here shall have the same meaning as ascribed to them in the Red Herring Prospectus. 

2 comments:

  1. forex trading is going to revolutionlize the money market entirely when Narayana Hrudayalaya Limited listen their shares for sale I did buy them I had to submit some order an essay before they could go ahead with the sale

    ReplyDelete
  2. This a good way to appreciate the teacher as they put their efforts to train students. UK dissertation Writers appreciates the teachers.  Stock education

    ReplyDelete

Post Top Ad

Responsive Ads Here